Ocugen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.88

+0.08 (+4.44%)

As of May 9, 1:50 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,494.1% upside

Low Target $22.68

Average Target $29.97

High Target $39.58

Current Price $1.88

Current
$1.88

Target
$29.97

$22.68 $29.97 avg $39.58

Scenario Analysis

Bear Case

$22.68

1,106.4%

Low target

Base Case

$29.97

+1,494.1%

Avg target

Bull Case

$39.58

+2,005.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.73

-31.0% from high

52-Week Low

$0.64

+193.8% from low

Target vs 52W High

$29.97

+999.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%